NVOS (Novo Integrated Sciences) ROCE %: -226.41% (As of May. 2024)


NVOS Novo Integrated Sciences Inc NVOS
12 GF Score
Price $0.00
View Full Analysis

What is Novo Integrated Sciences ROCE %?

Novo Integrated Sciences NVOS 12 ROCE % is -226.41% as of May. 2024. GuruFocus rates NVOS with a GF Score™ of 12/100.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Novo Integrated Sciences's annualized ROCE % for the quarter that ended in May. 2024 was -226.41%.

Novo Integrated Sciences  (OTCPK:NVOS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Novo Integrated Sciences ROCE % Related Terms

Novo Integrated Sciences ROCE % Historical Data

* Premium members only.

The historical data trend for Novo Integrated Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novo Integrated Sciences ROCE % Chart

Novo Integrated Sciences Annual Data
Trend Dec14 Dec15 Dec16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.18 -15.37 -9.98 -63.52 -29.94

Novo Integrated Sciences Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.64 -37.93 -50.99 -23.26 -226.41
NVOS
12GF Score
Novo Integrated Sciences Inc NVOS
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novo Integrated Sciences ROCE % Calculation

Novo Integrated Sciences's annualized ROCE % for the fiscal year that ended in Aug. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Aug. 2023 )  (A: Aug. 2022 )(A: Aug. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Aug. 2023 )  (A: Aug. 2022 )(A: Aug. 2023 )
=-8.152/( ( (40.873 - 14.075) + (35.563 - 7.905) )/ 2 )
=-8.152/( (26.798+27.658)/ 2 )
=-8.152/27.228
=-29.94 %

Novo Integrated Sciences's ROCE % of for the quarter that ended in May. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: May. 2024 )  (Q: Feb. 2024 )(Q: May. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: May. 2024 )  (Q: Feb. 2024 )(Q: May. 2024 )
=-42.612/( ( (34.949 - 9.959) + (35.327 - 22.676) )/ 2 )
=-42.612/( ( 24.99 + 12.651 )/ 2 )
=-42.612/18.8205
=-226.41 %

(1) Note: The EBIT data used here is four times the quarterly (May. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -226.41% mean?
Novo Integrated Sciences (NVOS) has a ROCE % of -226.41% as of May. 2024.
Is Novo Integrated Sciences' ROCE % too high?
Novo Integrated Sciences' current ROCE % is -226.41%. Overall, Novo Integrated Sciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Novo Integrated Sciences' ROCE % compare to BACK and NHLG?
Novo Integrated Sciences' ROCE % of -226.41% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novo Integrated Sciences's current ROCE % is -226.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novo Integrated Sciences stock overvalued right now?
Novo Integrated Sciences (NVOS) has a current ROCE % of -226.41%. The current ROCE % is -226.41%. Novo Integrated Sciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Novo Integrated Sciences (NVOS), the current ROCE % is -226.41% as of May. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Novo Integrated Sciences Business Description

Address 11120 NE 2nd Street, Suite 100, Bellevue, WA, USA, 98004
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services and product sales. Healthcare services generate the majority of revenue.
12GF Score

Get the complete analysis for NVOS

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price